Having a collaborative, trusted team with the experience and technology to effectively partner with you is critical to mitigate risk and ensure better outcomes for your targeted genetic medicines.

Purposeful Collaboration

Vyriad works as an extension of your team to engineer the most appropriate and effective viral delivery solution for your therapy. Armed with a deep understanding of our partners’ programs and cargoes, we take an integrative approach to therapeutic development so that scientific, manufacturing, and clinical decisions are made synergistically. Preclinical, manufacturing, and clinical trials teams all provide input simultaneously at every checkpoint during therapeutic development.

Flexible Partnerships

Nothing we do is off-the-shelf. Our collaborative approach combined with in-house expertise and capabilities in viral vector development allows for greater flexibility in our partnerships. We will work together to develop and realize bespoke viral delivery solutions optimized for the success of your program in the clinic.

Learn about our partnerships

Comprehensive Expertise and Infrastructure

By combining expertise and infrastructure across viral-based drug development, manufacture and clinical trials, Vyriad is built from the ground up to partner with gene therapy and gene editing organizations for the highest chance of success in the clinic. Proactive dialogue between R&D, clinical development and manufacturing drive a positive feedback loop of innovation.